Recombinant CD19 (Inebilizumab Biosimilar) antibody

Catalog No. ABIN7581284

This anti-CD19 (Inebilizumab Biosimilar) antibody is a Human Monoclonal antibody detecting CD19 (Inebilizumab Biosimilar) in ELISA, FACS, BLI, Func and SPR. Suitable for Human.

Quick Overview for Recombinant CD19 (Inebilizumab Biosimilar) antibody (ABIN7581284)

Target: CD19 (Inebilizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD19 (Inebilizumab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD19 (Inebilizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD19 Reference Antibody (inebilizumab)

Characteristics: Anti-CD19 Reference Antibody (inebilizumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 147.42 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Conditions: B-cell malignancies Chronic Lymphocytic Leukemia Multiple Myeloma Neuromyelitis optica spectrum disorder Scleroderma

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD19 (Inebilizumab Biosimilar)

Target: CD19 (Inebilizumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 147.42 kDa

UniProt: P15391